Lucy Johnson

MedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “An open label, adaptive, phase 1 trial of high-dose oral nitazoxanide in healthy volunteers: an antiviral candidate for SARS-CoV-2”.

An open label, adaptive, phase 1 trial of high-dose oral nitazoxanide in healthy volunteers: an antiviral candidate for SARS-CoV-2

medRxiv(2021)10.1101/2021.09.10.21263376

N/A

0DataRank · unranked

0 citations

Richard J. Fitzgerald, Geoffrey Saunders, Rebecca Lyon, Michael Fisher, Karen Martin +27 more

Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial

Nature Communications(2025)10.1038/s41467-025-61691-4

N/A

0DataRank · unranked

5 citations

Kayleigh Hill, Min Zhang, Charlotte Poile, Sean Ewings, Essa Y. Baitei +35 more